| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |